| Abbott (23) |  |
| Amgen (10) | |
| Astra-merck (6) | |
| Bayer (41) | |
| Boehringer-ingelheim (1) | |
| Bristol-myers-squibb (5) | |
| Dupont-merck (14) | |
| Eli lilly (5) | |
| Genentech (5) | |
| Genzyme (5) | |
| Glaxosmithkline (26) | |
| Hoechst-marion-roussel (4) | |
| Pasteur-merieux (8) | |
| Pfizer (22) | |
| Pharmaceutical industry (36) | |
| Pharmaceutical laboratory (1) | |
| Pharmacyclics (1) | |
| Roche pharmaceuticals (16) | |
| Sanofi-aventis (6) | |
| Stallergenes (1) | |
| Whitehall laboratories (3) | |
and Sproxil relies on large pharmaceutical companies to cover costs of its fake drug identification service.
and one resistant to Bayer Crop sciences Liberty herbicide (gluphosinate). They also found some plants that were resistant to both herbicides,
In effect, the study showed that the pharmaceutical industry would feel the impact of this trend due to the cost of maintenance medicine that is oeprohibitive even for upscale consumers. oethis trend will create new opportunities for food brands,
The surprising result prompted Pfizer, which acquired Rinat, to explore whether the drug instead could promote weight gain,
As pharmaceutical companies move some research to less expensive countries, the obese monkeys are following. This is a booming industry in China,
said the company is basically taking the tracking system it uses for the pharmaceutical industry and adopting it to the food business.
#Dr Julian Little, of Bayer Cropscience, the main manufacturer of neonictinoids, pointed out the US study has not been published
In the late 1990s, Bayer conducted trials on the product, known as Ropadiar in Europe, comparing its ability to control diarrhea in piglets caused by E coli with that of four of the company s products.
Ropadiar outperformed the Bayer products. Strange but true!##Dr. Lucio Nisoli, the Bayer product manager, wrote in his report on the trial.
Compared to the various anti-infectives, with Ropadiar I have obtained much more effective and quicker results.
#Astrid KÃ hler, a spokeswoman in Monheim, Germany, for Bayer Healthcare s animal health business, confirmed that the company had done the trial
Sleep Better Researchers at Merck have created a pill called suvorexant that essentially makes you a narcoleptic for a night.
#12 amazing examples of environmental art ives of Grass by Mathilde Roussel Soil, wheat seeds, recycled metal and fabric Brooklyn, New york,
For instance, in Lives of Grass by Mathilde Roussel, a work that features two grass covered figurative sculptures, Roussel explores the cyclic metamorphosis that transforms organic matter whether vegetable, animal or human.
and the biochemistry lab that led to Amgen. But Boulder wasn t always so affluent, so collegiate, so pretty.
as a biochemistry professor in 1980, helped start the biotech firm Amgen. His cofounders decided to put company headquarters in Thousand Oaks
Veterans of his department, of Amgen, and of the university s biology departments would go on to start biotech firms,
pharmaceutical giant Sanofi, has manufactured 35 tons of artemisinin#roughly equivalent to 70 million courses of treatment.
and will be run by Arthur Levinson, chairman and ex-CEO of biotech company Genentech. Google gave exclusive access to Time magazine for a story on the new venture.
Arthur D. Levinson, Chairman and former CEO of Genentech and Chairman of Apple, will be Chief executive officer and a founding investor.
#Art Levinson will remain Chairman of Genentech and a director of Hoffmann-la roche, as well as Chairman of Apple.
Chairman of Hoffmann-la roche, said:##oeart s track record at Genentech has been exemplary, and we see an interesting potential for our companies to work together going forward.
We re delighted he ll stay on our board.##Tim cook, Chief executive officer of Apple, said:##oefor too many of our friends and family, life has been cut short
Art Levinson, Chairman and former CEO of Genentech and Chairman of Apple, will be Chief executive officer. OK#so you re probably thinking wow!
and hydrogenated oil said Melissa Abbott culinary director at the Hartman Group a company specializing in consumer research.
Louis Pasteur was the first zymologist discovering that yeast led to fermentation. Some universities even have programs now where students can major in fermentation sciences.
Patenting a medicine is one way for a pharmaceutical company to prevent others from copying their drug.
and thus cannot be patented a major way that pharmaceutical companies make money Nedergaard said. Capsinoids come from sweet chili peppers that don't taste hot
Drugs made by pharmaceutical companies for instance go through many years of expensive highly-controlled clinical trials comparing the effects of the new drug against a placebo control.
what some of Eben Bayer and Gavin Mcintyre s fellow students at Rensselaer Polytechnic institute thought too.
Bayer and Mcintyre soon co-founded Ecovative Design and focused on creating mycelium-based wall insulation
Don't forget to think about antibiotics said study researcher Dr. Anne Des Roches an allergist at CHU Sainte-Justine a health center affiliated with the University of Montreal in Quebec.
they have to send the sample to special laboratories to perform an analysis Des Roches said.
But the pharmaceutical industry is often dismissive of nature as a source of healing. It seems to overlook the fact that many of the most important classes of prescription drugs like ACE inhibitors for high blood pressure (first developed from Brazilian snake venom) beta blockers (from hallucinogenic Mexican fungi)
I briefly discussed Sundrop Farms in an article for The Conversation late last year on the CEFC which is targeted to be scrapped by the Abbott government.
Chinchilla fur was mottled originally yellow-gray in the wild according to The Merck Veterinary Manual. Through selective breeding however other colors have become common including silver yellow-gray bluish-gray white beige and black.
Chris Corrigan lectures for Glaxosmithkline and Allergy Therapeutics and consults for Novartis Stallergenes and Allergy Therapeutics.
He has received funding from the Medical Research Council the Wellcome Trust Asthma UK Glaxosmithkline Allergopharma and various other charities
and taken by WHO were influenced not improperly by the pharmaceutical industry, says Keiji Fukuda. 2 january 2010:
European Medicines Agency recommends approval of two H1n1 vaccines, from Novartis and Glaxosmithkline. 15 september 2009:
and Sanofi Pasteur. 10 september 2009: Two papers published in the New england Journal of Medicine show two new vaccines against H1n1 are likely to be effective after just one dose (paper 1,
including oseltamivir (marketed by Roche as Tamiflu) and zanamivir (marketed by Glaxosmithkline as Relenza), are effective against the new pandemic virus in human cells grown in the lab. These drugs are already being used to treat some infected patients.
Meanwhile Kawaoka's studies generally echo the findings of two Science papers released last week,
Eli lilly abandoned development of its osteoporosis drug arzoxifene, after results from an advanced clinical trial suggested it did not offer sufficient benefit over currently available treatments.
Meanwhile, Amgen, of Thousand Oaks, California, has received more positive news for its new-mode-of-action osteoporosis treatment, denosumab.
The drug company Abbott laboratories in Abbott Park, Illinois, is to buy Solvay Group's pharmaceutical business for  4. 5 billion (US$6. 6 billion.
The acquisition will also see Abbott increase its annual US$2. 7-billion pharmaceutical research and development investment by $500 million.
If companies such as Germany's Bayer Materialscience, headquartered in Leverkusen, and Tokyo-based Showa Denko follow through with similar plans,
Following a fortnight of political turmoil that saw climate-change sceptic Tony Abbott elected as leader of the opposition,
Drug-maker Glaxosmithkline (GSK) was aware of cardiac risks associated with its diabetes drug Avandia (rosiglitazone) years before they became public
GSK says that the Senate report cherry-picked information and mischaracterized its efforts to research
BASF is hoping to break into a market dominated by Monsanto, Syngenta, Dupont and Bayer; its'Amflora'genetically modified starchy potato is awaiting European union approval.
London-based pharma giant Glaxosmithkline revealed plans on 4 february to shut down early-stage research into pain and depression medications,
Business Pfizer payments: On 31 march, the drug company Pfizer began to make public its payments to physicians
and other health professionals for speaking and consulting on its behalf, and for conducting clinical trials of its drugs.
Pfizer said it paid out US$35 million in the last six months of 2009. It was required to post much of the data by an agreement settling a US government investigation into the company's promotion of its drugs for off-label use.
Glaxosmithkline, Merck and Eli lilly already publicly report physician payments; this will be mandatory from 2013, under US health-care reform law.
Business Genzyme fined: On 24 may, the US Food and Drug Administration (FDA) fined Genzyme US$175 million for poor oversight at one of its manufacturing plants.
Efforts by the biotechnology company, based in Cambridge, Massachusetts, to clean the plant will cause shortages of three drugs,
on 25 may, after years of struggle, Genzyme won FDA approval to market Lumizyme (alglucosidase-Ã Â) for patients with late-onset Pompe disease, a muscle-weakening illness.
Amgen has secured regulatory approval from the European commission for denosumab (Prolia), the California-based drug company's treatment for osteoporosis. The monoclonal antibody will be used to treat postmenopausal women who have increased an risk of fractures,
Astrazeneca has hired Pfizer's research and development (R&d) chief, Martin Mackay, to take the helm of its own R&d programme.
Pfizer and Astrazeneca are both restructuring their R&d programmes to replenish pipelines and cut costs.
Mackay became head of R&d at Pfizer, the world's biggest drug maker, in 2007,
when Pfizer completed its acquisition of rival Wyeth. Dolsten will now lead Pfizer's R&d team alone.
Business watch A growing need to cut pharmaceutical and biotechnology research costs is fuelling a boom in the contract research organization (CRO) industry.
Aspen, which is owned 19 by pharmaceutical giant Glaxosmithkline, headquartered in London, and is Africa's largest drugs manufacturer,
and drug behemoth Merck, headquartered in Whitehouse Station, New jersey, both released promising results from late-stage clinical trials of their leading drugs against the hepatitis C virus (HCV).
Merck's drug boceprevir and Vertex's telaprevir both block HCV's protease enzyme and 墉 combined with the standard treatment 墉 cured 66%and 72%of patients respectively in phase
and one resistant to Bayer Crop science's Liberty herbicide (gluphosinate). They also found some plants that were resistant to both herbicides,
which includes the pharmaceutical multinationals Pfizer and Astrazeneca, will also design software to make the results useful to researchers and clinicians.
By genotyping patients for a broad array of cancer-causing mutations, the new tests will make it easier to assign subjects to clinical trials,
Business Pharma chiefs After four years as chief executive of New york-based drug company Pfizer, Jeffrey Kindler announced his retirement on 6 december.
Pharmaceutical company Merck & Co. of Whitehouse Station, New jersey, made a more expected announcement on 30 november,
Red wine drug Drug company Glaxosmithkline (GSK) has halted all development of a proprietary formulation of resveratrol a chemical found in red wine
was being tested by GSK and its subsidiary, Sirtris in Cambridge, Massachusetts, against several conditions, including multiple myeloma.
But GSK, of London, has scuttled development of SRT501, it confirmed to the patient website Myeloma Beacon last week.
2011 墉 takes place at the UN headquarters in New york. go. nature. com/potx5i Number crunch 18%The number of health advocacy groups receiving funding from Eli lilly in the first
The world's best-selling drug 墉 Pfizer's cholesterol-lowering medication Lipitor (atorvastatin) 墉 may face competition from generics maker Ranbaxy of Gurgaon, India.
Other blockbusters due to come off patent include Sanofi-aventis's anti-clotting drug Plavix (clopidogrel) and Eli lilly's schizophrenia drug Zyprexa (olanzapine.
Pharmaceutical companies usually have little incentive to research and produce affordable vaccines for poor nations. But the initiative
and asked for a third to be pulled off the Market research cutback Pharmaceutical giant Pfizer on 1 february announced cuts to its research budget
Massachusetts, was given the green light on 23 may 墉 10 days after the agency approved boceprevir (Victrelis) made by Merck of Whitehouse Station, New jersey.
says Johan Botterman, head of product research at Bayer Bioscience in Ghent, Belgium. The technique is established well for many crops,
) Bayer is interested in harnessing other enzymes called'meganucleases'to do the same type of targeted engineering,
Earlier this year, Genzyme, a drug company based in Cambridge, Massachusetts, that makes alemtuzumab and a range of other therapies, was acquired by Paris-based drug-maker Sanofi.
The value of the deal for Genzyme's shareholders is contingent on the success of alemtuzumab in treating MS;
the first milestone is for the drug to gain approval from the US Food and Drug Administration before the end of March 2014.
BUSINESSVIOXX fines Drug-maker Merck will pay US$950 million to settle investigations into how it marketed the painkiller Vioxx,
Merck had set aside the money in the third quarter of 2010. Lipitor patent ends The world's best-selling drug, Pfizer's cholesterol-lowering medication Lipitor (atorvastatin) now faces competition from generics,
after it lost patent protection on 30 november. The drug has brought in more than US$100 billion in sales for the pharma company,
based in New york, which has had to slash research and development funding as it tries to make up for the expected loss in income.
Business Avandia fine Drug giant Glaxosmithkline (GSK) announced on 3 november that it has agreed to pay US$3 billion to settle a bevy of US federal investigations into the way it has developed
when a US Senate committee concluded that GSK had known about the drug's heart risks for more than a decade without reporting them to regulators.
¢â presents recommendations for avoiding future food crises. ccafs. cgiar. org/commission Number crunch $131 bn Lifetime sales of Pfizer's cholesterol-lowering drug
Amgen shake-up Two top executives at the biotechnology giant Amgen are leaving after more than a decade in charge,
Amgen, based in Thousand Oaks, California, posted US$15. 1 billion in sales last year; its products include biological drugs for rheumatoid arthritis and anaemia.
Moshe Yaniv, a geneticist at the Pasteur institute, and Jean Rossier, a neurobiologist at ESPCI Paristech.
Hepatitis C hopefuls Pharmaceutical giant Bristol-myers squibb of New york city has become the latest company to spend billions on the promise of hepatitis C treatments.
Jeremy Levin, former head of strategy and alliances at Bristol-myers squibb in New york city, has a reputation for making external partnerships
has rejected, as expected a US$5. 7-billion takeover bid by drug giant Roche, based in Basel, Switzerland.
Roche replied that its bid was"full and fair. The firm is expected now to start wooing Illumina's major investors to accept a takeover
even though Illumina's share price is currently well above Roche's bid. Synbio troubles US synthetic biology firm Amyris which engineers microbes to process plant sugars into useful chemicals saw its share price plunge by 28%on 10 february,
head of the Molecular genetics of RNA VIRUSES lab at the Pasteur institute in Paris. One reason is that many of the virus samples are sequenced in retrospective research studies.
One investigation, known as the Whitehall study2, found that low-ranking British civil servants suffer higher rates of illness and death than their superiors.
who led the Whitehall study.""Clearly, changing ranks leads to changes in gene expression and not the other way around, he says.
The macaque study suggests potential mechanisms for the Whitehall study's findings, Marmot adds. The link between genes and social status may be more difficult to tease out in humans than in monkeys,
and pharmaceutical laboratories, has bred so far about 275 Â pigs some with cystic fibrosis, others with heart disease, arrhythmia or cancer,
Swart calls the wait worthwhile if Exemplar s pigs can help pharmaceutical companies to predict whether a drug will work."
Pharma fines Drug giant Glaxosmithkline will pay US$3 billion in fines for enormous health-care fraud.
Pharma closure About 1, 000 Â jobs are to be lost with the closure of pharmaceutical company Roche s research site in Nutley
Roche said the 80-year-old base would cease operation by the end of 2013;
Bristol-myers squibb and Astrazeneca, are teaming up to acquire the biotech firm Amylin, based in San diego, California, for US$5. 3 Â billion (or $7 Â billion with existing contractual obligations).
Bristol-myers squibb, headquartered in New york city, is buying Amylin for its lucrative diabetes treatments. As part of the deal, announced on 29 Â June,
Amylin will receive $3. 4 Â billion from London-based Astrazeneca, and the two firms will share profits and losses from Amylin s drugs pipeline.
Drug-discovery split Irish pharmaceutical company Elan is to split into two, completely separating its drug-discovery work from the main business.
Pharmaceutical companies Johnson & johnson, based in New brunswick, New jersey, and Pfizer, based in Groton, Connecticut, said on 6 Â August that they would no longer work on the monoclonal antibody bapineuzumab.
It binds a peptide, amyloid-Ã Â, that may cause neurodegeneration in patients with Alzheimer s.
21 27 september 2012drug-makers unite Ten giant pharmaceutical companies have formed a nonprofit organization called Transcelerate Biopharma, with the goal of making clinical trials more efficient.
A company that later became part of Glaxosmithkline patented AZT in the 1980s when it was found to be effective against AIDS.
and senior vice-president at the UK-based drug firm Pfizer, died on 22 Â January. Cox s research group at Pfizer aimed to find a way to arrange clinical-trial participants on the basis of their genetic make-up.
He was also a member of one of the teams that led the Human genome Project,
Bayer, a chemical company based in Leverkusen, Germany, which manufactures imidacloprid and clothianidin, said in a statement that it does not believe that the EFSA s reports"alter the quality
Pharma split Abbott laboratories has spun off its drug-discovery business into an independent company called Abbvie,
Abbott based in Abbott Park, Illinois, will retain its medical devices, diagnostics, nutritional products and generic pharmaceutical business.
Abbvie, headquartered in North Chicago, Illinois, previously functioned as an Abbott subsidiary; it earned US$17. 4 Â billion in 2011.
The now-separate firm plans to expand the market for its blockbuster anti-inflammatory antibody Humira (adalimumab),
On the same day, Illumina s share price dropped by 7%after drug giant Roche said that it did not plan to buy the company.
While working at the Pasteur institute in Paris, he identified regulatory proteins that bind to DNA,
and H5n1. gm. asm. org21-23 may The Pasteur institute in Paris hosts an international symposium on HIV research,
Pharma probe The Chinese government is investigating four senior executives of Glaxosmithkline (GSK) in China for allegedly bribing officials
and physicians to boost GSK drug sales, funnelling the money through travel agencies. The executives are suspected of giving 3 Â billion renminbi (US$489 Â million) in bribes since 2007
The government says that the probe is part of nationwide crackdown to ensure fair competition in the pharmaceutical industry.
GSK, headquartered in London, says that it is conducting its own review and is cooperating with the Chinese police.
) Alzheimer s retest Eli lilly, a pharmaceutical company based in Indianapolis, Indiana, announced on 12 Â July that it will focus on patients with mild Alzheimer s disease in a forthcoming clinical trial of the drug solanezumab.
Gary Nabel, a flu-vaccine researcher and chief scientific officer at the biotechnology firm Sanofi in Cambridge, Massachusetts, agrees."
Ibrutinib, developed by Pharmacyclics of Sunnyvale, California, is only the second drug to be approved under the FDA s Breakthrough Therapy Designation programme a pipeline launched last year to fast-track regulatory approval of particularly promising treatments.
and mergers among pharmaceutical companies may be behind the fall in global output. 22 november The European space agency is scheduled to launch Swarm,
which some analysts had taken as a signal of revived fortunes in the pharmaceutical industry. The agency told reporters that it had received fewer drug applications for review in 2013
7 13 february 2014sharing drug data Ten major pharmaceutical companies have agreed to share data from early-stage trials with each other and with academic researcher,
Among companies, Astrazeneca had the most public-private partnerships, including its deal with Sweden s Karolinska Institute to create a US$100-million cardiac-research centre.
Every year the pharmaceutical industry spends more than $39 billion on R&d. According to the Food and Drug Administration liver toxicity is the most common reason for a drug to be pulled from clinical trials as well as from the marketplace after it's been approved.
IMO the pharmaceutical companies are using a classic misdirection. The people I have heard and the data I have seen is not against vaccines
The pharmaceutical companies need a safer preservative than thirmerosal but that would cost money to develop.
Popular science should do a lot more research not just listen to the drug and pharmaceutical industry.
and the pharmaceutical industry with all the light thats been shining on their dark sides recently. Thanks Popsci for making my decision to cancel that much easier.
Most specifically the GSK paxil case wherein they used a ghostwriter to say the drug was safe.
is laced with Monsanto and Bayer's Systemic Neurotoxins. So not only are fed they a diet of junk food...
It's going great. the problem is bayer's neonicotinoid pesticides they accumulate in the plants
First this doesn't seem to be a pharmaceutical company. They're not making or selling drugs to anyone.
You will notice items like pasteurized nonfat milk a variety of nonfat milk that comes not from the pasteurization process but from the Pasteur Cows of the Lower Himalayan Range.
After that however they go into a big cylindrical bioreactor like the ones used in the pharmaceutical industry today.
The work should be significant for pharmaceutical companies that design drugs through painstaking processes and at great cost by eliminating some of the trial and error in identifying new sites on proteins that could be manipulated more easily to treat disease said Rice biological physicist Jos Onuchic.
At the Botanical garden's Pfizer Plant Research Laboratory they worked with Garden scientist Dr. Damon Little to generate DNA barcodes for all of the individuals
Professor Abbott and his team at the Department of chemistry at the University of Leicester have developed a new wood-based product similar to MDF that uses a resin based on starch from completely natural sources including potatoes.
Professor Abbott's new resin means that the use of UF is avoided and therefore so too are associated the concerns.
Today (31 october) Professor Andrew Abbott is awarded the Royal Society Brian Mercer Award for Innovation 2013 that will help him make the critical step from prototype to product.
Professor Abbott's new material is easier to manufacture and easier to work with than current MDF boards.
On receiving the Royal Society Brian Mercer Award for Innovation Professor Abbott said: The Brian Mercer Award is fundamental in enabling us to take this project forward to the next stage;
Professor Abbott will receive £172347 which will be used to bring the four collaborators together to create a supply chain to create prototypes for the point-of-sale market.
Professor Abbott and his group at University of Leicester are also developing new fillers for plastics based on orange and banana peel and eggshell.
Amanda Bayer lead author of the research study explained that most often horticultural best management practices (BMPS) are used to conserve water
and improved water conservation compared with traditional irrigation practices Bayer said. Bayer and colleagues Imran Mahbub Matthew Chappell John Ruter and Marc van Iersel from the Department of Horticulture at the University of Georgia published their research findings in the August 2013 issue
of Hortscience. We designed a project to quantify the growth of Hibiscus acetosella'Panama Red'in response to various soil water content thresholds explained Bayer.
The team performed the experiments in a greenhouse and on outdoor nursery pads using soil moisture sensors to maintain soil water content above specific thresholds.
and at the University of Georgia Tifton Campus. Bayer explained that the studies were conducted in two different U s. Department of agriculture hardiness zones (Tifton 8b Watkinsville 8a) to compare plant responses under different
Bayer added that along with reduced water use and growth control more efficient soil moisture sensor-controlled irrigation could greatly reduce leaching allowing for reductions in fertilizer applications.
The scientists found that apigenin inhibited an enzyme called glycogen synthase kinase-3î (GSK-3î) which led to a decrease in the production of anti-apoptotic genes in the pancreatic cancer cells.
Ronald Bayer Phd Mailman School professor of Sociomedical Sciences and senior author of the Health Affairs paper says this change in attitudes was also a sign that bans might be self-enforcing requiring little intervention
But as Dr. Bayer notes the health risk of exposure is far less certain than some supporters claimed.
In the argument for smoking bans in parks and on beaches the most striking aspect according to Dr. Bayer is the assertion that just the act of smoking in public poses a threat to the well-being of children
and hospitality industries and of people who invoke threats of Big brother writes Dr. Bayer. While the rules for bans on smoking in public are gaining in popularity
and death in the short term Dr. Bayer and co-author Kathleen E. Bachynski suggest that healthcare policymakers will need to make a stronger case with more conclusive evidence to gain the public trust.
Beach and park bans represent measures that contribute to those goals said Dr. Bayer. Tobacco is the number-one preventable cause of death in the United states
Additional co-authors include researchers from Mcmaster University (Canada) the Russian Academy of Sciences and Bayer Cropscience (Germany.
and Prof Damien Roussel at the Ecology of Natural and Man-impacted Hydrosystems laboratory in France looked for the first time at how the king penguin chicks'mitochondria in skeletal muscle the main heat producing tissue in birds function during fasting in the winter.
and water quality especially with cattle grazing said lead author Leslie Roche a postdoctoral scholar in the UC Davis Department of Plant sciences.
and support from Roche Applied science's 10 Gigabase Grant Program to understand the unique roles of fungi and bacteria.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011